You, Q <br/><br/>
Subcutaneous administration of modified vaccinia virus Ankara expressing an Ag85B-ESAT6 fusion protein, but not an adenovirus-based vaccine, protects mice against intravenous challenge with Mycobacterium tuberculosis.  [electronic resource] 

 -  Scandinavian journal of immunology  Jan 2012 
 - 77-84 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>1365-3083 
<br/><br/><label>Standard No.: </label>10.1111/j.1365-3083.2011.02629.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acyltransferases--genetics<br/>Animals<br/>Antigens, Bacterial--genetics<br/>Bacterial Proteins--genetics<br/>CD4-Positive T-Lymphocytes--immunology<br/>CD8-Positive T-Lymphocytes--immunology<br/>Cytotoxicity, Immunologic--immunology<br/>Histocytochemistry<br/>Humans<br/>Interferon-gamma--analysis<br/>Mice<br/>Mice, Inbred BALB C<br/>Mycobacterium tuberculosis--immunology<br/>Specific Pathogen-Free Organisms<br/>Statistics, Nonparametric<br/>Tuberculosis--immunology<br/>Tuberculosis Vaccines--immunology<br/>Vaccination--methods<br/>Vaccines, Synthetic--genetics<br/>Vaccinia virus--genetics